CellPilot™: Tailor Immune Cell Function with Unmatched Flexibility and Scale6 Nov 20256 Nov 2025Flyers
Speed Meets Precision: Tailored Immune Cell Function through Rapid Quantitative Immunology6 Nov 20256 Nov 2025White Papers
Accelerating Cell Therapy: Navigating Immune Mediation with Comprehensive Cell Interaction Screening6 Nov 20256 Nov 2025White Papers
A Configurable, Cross-Modality Extracellular Vesicle Standard (EV-CMS) Enables Quantitative Evaluation Across Nanotechnology Platforms6 Nov 20256 Nov 2025Posters
Selective Programming Drives Faster Expansion of Antigen-Specific T cells to Improve Cell Therapy Manufacturing and Outcomes6 Nov 20256 Nov 2025Posters
High Throughput Screening of a Programmable Cellular Interface (sbPCI) Rapidly Identifies Configurations Capable of Expanding T Cell Subsets Without Isolation6 Nov 20256 Nov 2025Posters
StimulusBio CEO Presents at TLSF 2024: Non-Dilutive Funding for Life Science Companies7 Nov 202415 Sep 2025Events
The Science of Success: Transforming Scientific Concepts into Marketable Products with Stacie Frye, co-founder and CCO of Stimulus Bio30 Oct 202415 Nov 2024Podcasts
